Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David R. Spriggs, MD
Memorial Sloan Kettering Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
52 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama Comprehensive Cancer Center
Birmingham, Alabama, United States
- Jonsson Comprehensive Cancer Center, Ucla
Los Angeles, California, United States
- Usc/norris Comprehensive Cancer Center
Los Angeles, California, United States
- Chao Family Comprehensive Cancer Center
Orange, California, United States
- Women'S Cancer Center
Palo Alto, California, United States
- University of Colorado Cancer Center
Denver, Colorado, United States
- Vincent T. Lombardi Cancer Research Center, Georgetown University
Washington D.C., District of Columbia, United States
- Walter Reed Army Medical Center
Washington D.C., District of Columbia, United States
- H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
- Emory University Hospital - Atlanta
Atlanta, Georgia, United States
- Mbccop - Hawaii
Honolulu, Hawaii, United States
- Rush-Presbyterian-St. Luke'S Medical Center
Chicago, Illinois, United States
- University of Chicago Cancer Research Center
Chicago, Illinois, United States
- Ccop - Central Illinois
Decatur, Illinois, United States
- Indiana University Cancer Center
Indianapolis, Indiana, United States
- University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
- Albert B. Chandler Medical Center, University of Kentucky
Lexington, Kentucky, United States
- Johns Hopkins Oncology Center
Baltimore, Maryland, United States
- University of Massachusetts Memorial Medical Center
Worcester, Massachusetts, United States
- Ccop - Ann Arbor Regional
Ann Arbor, Michigan, United States
- Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, United States
- University of Minnesota Cancer Center
Minneapolis, Minnesota, United States
- University of Mississippi Medical Center
Jackson, Mississippi, United States
- Ccop - Kansas City
Kansas City, Missouri, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Cooper Hospital/university Medical Center
Camden, New Jersey, United States
- Cancer Center of Albany Medical Center
Albany, New York, United States
- State University of New York Health Science Center at Brooklyn
Brooklyn, New York, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- University of Rochester Cancer Center
Rochester, New York, United States
- Lineberger Comprehensive Cancer Center, Unc
Chapel Hill, North Carolina, United States
- Duke Comprehensive Cancer Center
Durham, North Carolina, United States
- Comprehensive Cancer Center of Wake Forest University Baptist Medical Center
Winston-Salem, North Carolina, United States
- Barrett Cancer Center, the University Hospital
Cincinnati, Ohio, United States
- Cleveland Clinic Cancer Center
Cleveland, Ohio, United States
- Ireland Cancer Center
Cleveland, Ohio, United States
- Arthur G. James Cancer Hospital - Ohio State University
Columbus, Ohio, United States
- University of Oklahoma College of Medicine
Oklahoma City, Oklahoma, United States
- Abington Memorial Hospital
Abington, Pennsylvania, United States
- Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 1996
- Primary completion
- 31 Oct 2007
- Completion
- —
- Last update posted
- 27 May 2013
- Registered enrollment
- 324
- Registry id
- NCT00002717
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.